FDA Clearance Tracker · P010032-S237
Eterna SCS and Proclaim SCS Systems
Last checked: Nov 20, 2026Latest source record: Jan 13, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Jan 13, 2026
Approved
Time to decision
249 days
Received May 9, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P010032-S237
- Device name
- Eterna SCS and Proclaim SCS Systems
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Plano, TX
- Received
- May 9, 2025
- Decided
- Jan 13, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P010032
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
approval for labeling changes to expand the Magnetic Resonance (MR) Conditional labeling to include prone positioning for the Eterna and Proclaim SCS Systems, as well as update the radiofrequency (RF) heating conditions and lead tip implant location for supine positioning for the Proclaim SCS System to ensure consistency in the labeling between the Eterna and Proclaim SCS Systems
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
- EnSite X EP System510(k)
K261729 · Decided Sep 17, 2026 · 114 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
- TactiFlex Duo Ablation Catheter, Sensor Enabled (A-TFDM-D, A-TFDM-F, A-TFDM-J, A-TFDM-DD, A-TFDM-DF, A-TFDM-FF, A-TFDMPMA supplement
P220013-S028 · Decided Sep 4, 2026 · 186 days after receipt · Panel Track
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.